194 related articles for article (PubMed ID: 38061987)
1. A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer's disease.
Darvesh S; Banfield S; Dufour M; Forrestall KL; Maillet H; Reid GA; Sands D; Pottie IR
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2225797. PubMed ID: 38061987
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.
Darvesh S; Reid GA; Martin E
Curr Alzheimer Res; 2010 Aug; 7(5):386-400. PubMed ID: 19939227
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
5. Thioesters for the in vitro evaluation of agents to image brain cholinesterases.
Macdonald IR; Jollymore CT; Reid GA; Pottie IR; Martin E; Darvesh S
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):447-55. PubMed ID: 22233541
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy.
Barré A; Azzouz R; Gembus V; Papamicaël C; Levacher V
Molecules; 2019 Apr; 24(7):. PubMed ID: 30939771
[TBL] [Abstract][Full Text] [Related]
7. The use of cholinesterases in ecotoxicology.
Nunes B
Rev Environ Contam Toxicol; 2011; 212():29-59. PubMed ID: 21432054
[TBL] [Abstract][Full Text] [Related]
8. Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.
Yang H; Du C; Li Q; Chen T; Lu X; Li Q; Feng F; Chen Y; Liu W; Sun H
Bioorg Chem; 2019 Nov; 92():103294. PubMed ID: 31557623
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
Giacobini E
Drugs Aging; 2001; 18(12):891-8. PubMed ID: 11888344
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent kinetic complexities in cholinesterase-catalyzed reactions.
Masson P
Biochemistry (Mosc); 2012 Oct; 77(10):1147-61. PubMed ID: 23157295
[TBL] [Abstract][Full Text] [Related]
12. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
13. Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.
Jollymore-Hughes CT; Pottie IR; Martin E; Rosenberry TL; Darvesh S
Bioorg Med Chem; 2016 Nov; 24(21):5270-5279. PubMed ID: 27637382
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual cholinesterase inhibitors.
Banoo R; Nuthakki VK; Abdullaha M; Sharma M; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1791-1802. PubMed ID: 36112736
[TBL] [Abstract][Full Text] [Related]
15. The Interaction Between Two Metabolites of Polygala tenuifolia and Cholinesterases.
Gao C; Du H
Protein Pept Lett; 2022; 29(12):1051-1060. PubMed ID: 36028966
[TBL] [Abstract][Full Text] [Related]
16. Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease.
Saeedi M; Safavi M; Allahabadi E; Rastegari A; Hariri R; Jafari S; Bukhari SNA; Mirfazli SS; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000101. PubMed ID: 32657467
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterases: roles in the brain during health and disease.
Ballard CG; Greig NH; Guillozet-Bongaarts AL; Enz A; Darvesh S
Curr Alzheimer Res; 2005 Jul; 2(3):307-18. PubMed ID: 15974896
[TBL] [Abstract][Full Text] [Related]
18. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Mishra P; Kumar A; Panda G
Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
